Tomoko Nakano
Overview
Explore the profile of Tomoko Nakano including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
284
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ohashi Y, Kuriyama S, Nakano T, Sekine M, Toyoda Y, Nakayama A, et al.
Am J Kidney Dis
. 2022 Jul;
81(2):134-144.e1.
PMID: 35810827
Rationale & Objective: Treatment of asymptomatic hyperuricemia is not commonly implemented. However, it is unclear whether urate deposition that begins during asymptomatic hyperuricemia can induce nephropathy. Dysfunction of ATP-binding cassette...
2.
Honda K, Kuriyama S, Ichida K, Nakano T, Sugano N, Yokoo T
BMC Nephrol
. 2021 Jun;
22(1):207.
PMID: 34078313
Background: Insulin-like growth factor-1 (IGF-1) acts on glucose and protein metabolism and human growth and also influences blood pressure and renal function. This study investigated whether the single-nucleotide polymorphism of...
3.
Niwa Y, Imai K, Kotani T, Nakano T, Ushida T, Moriyama Y, et al.
J Clin Ultrasound
. 2019 Jul;
47(8):494-496.
PMID: 31287158
Typical ultrasound findings of fetal abdominal lymphangioma include thick-walled, multiseptated anechoic masses. Although a majority of cases can be suspected promptly by ultrasound examination, the two cases presented herein did...
4.
Imai K, Kotani T, Ushida T, Moriyama Y, Nakano T, Kikkawa F
J Obstet Gynaecol
. 2019 Apr;
39(6):757-762.
PMID: 31020886
Postpartum haemorrhage (PPH) is a potentially life-threatening condition. Women undergoing caesarean section (CS) are at particular risk, and improvements in the management of PPH during CS are required. We investigated...
5.
Matsukawa S, Sumigama S, Kotani T, Wang J, Miki R, Moriyama Y, et al.
Gynecol Obstet Invest
. 2019 Feb;
84(4):396-406.
PMID: 30759440
Background/aims: The study aimed to evaluate molecular changes related to trophoblast adhesion in placenta accreta spectrum (PAS) disorders. Methods: A retrospective analysis of 10 PAS cases in which both the...
6.
Niwa Y, Imai K, Kotani T, Miki R, Nakano T, Ushida T, et al.
Early Hum Dev
. 2019 Jan;
129:65-70.
PMID: 30684905
No abstract available.
7.
Imai K, Kotani T, Nakano T, Ushida T, Kikkawa F
Taiwan J Obstet Gynecol
. 2018 Dec;
57(6):899-900.
PMID: 30545551
No abstract available.
8.
Sumigama S, Enomoto A, Matsukawa S, Ushida T, Imai K, Nakano T, et al.
J Obstet Gynaecol
. 2018 Nov;
39(4):545-546.
PMID: 30406702
No abstract available.
9.
Mizuno M, Miki R, Moriyama Y, Ushida T, Imai K, Niimi K, et al.
Mol Med Rep
. 2018 Nov;
19(1):293-301.
PMID: 30387815
Recent studies have reported that E2F transcription factor (E2F) 8, an atypical E2F transcription factor, serves a critical role in promoting the growth and development of the murine placenta. However,...
10.
Imai K, Kotani T, Tsuda H, Nakano T, Ushida T, Iwase A, et al.
Sci Rep
. 2018 Jun;
8(1):9221.
PMID: 29907804
The aim of the present study was to investigate long-term outcomes of the offspring in a lipopolysaccharide (LPS)-induced maternal immune activation (MIA) model and the effect of maternal molecular hydrogen...